HB Wealth Management’s Sana Biotechnology SANA Stock Holding History

HB Wealth Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$35.8K	Buy	+12,270	New	+$42.7K	﹤0.01%	1853

Other funds holding SANA

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

T3 Companies New York $103M AUM 54.73% 1-Year Est. Return

VCM

Viewpoint Capital Management Seattle, Washington $214M AUM 18.61% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $851M AUM 28.55% 1-Year Est. Return

Prodigy Asset Management Omaha, Nebraska $335M AUM 5.94% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return

HB Wealth Management's SANA Position: Q3 2026 in Review

HB Wealth Management opened a new position in Sana Biotechnology (SANA) in Q3 2026: 12,270 shares worth $35.8K. The stake represents ﹤0.01% of the portfolio and ranks #1853 among its holdings.

34 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

HB Wealth Management held 12,270 shares of Sana Biotechnology worth $35.8K as of Q3 2026.
Sana Biotechnology was a new HB Wealth Management position in Q3 2026.
Sana Biotechnology made up ﹤0.01% of HB Wealth Management's portfolio in Q3 2026, its #1853 holding.
34 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on HB Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.